CAAS
BSX icon

Capital Asset Advisory Services’s Boston Scientific BSX Stock Holding History

Capital Asset Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,438
Closed -$942K – 378
2026
Q1 		$942K Buy
+15,438
New +$1.24M 0.04% 145
2021
Q1 		– Sell
-1,124
Closed -$40K – 765
2020
Q4 		$40K Buy
+1,124
New +$40.5K 0.01% 670

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Capital Asset Advisory Services's BSX Position: Q2 2026 in Review

Capital Asset Advisory Services sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 15,438 shares — an estimated $942K sold.

Capital Asset Advisory Services first reported a position in BSX in Q4 2020 and held it in 2 quarters. The position peaked at $942K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capital Asset Advisory Services reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Capital Asset Advisory Services sold 15,438 Boston Scientific shares in Q2 2026, an estimated $942K.
  • Capital Asset Advisory Services first reported a position in Boston Scientific in Q4 2020 and held it in 2 quarters.
  • Capital Asset Advisory Services's Boston Scientific position peaked at $942K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital Asset Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.